Midrodine Recall Paused While FDA Reviews Drug Data
Federal drug safety reviewers are backing off threats to force a recall of midrodine, which is marketed as ProAmantine, indicating that they will give the manufacturers of the low blood pressure…
Tag Archives: ProAmantine
-
-
ProAmatine Recall: FDA Proposes to Withdraw Drug Approval
The FDA is proposing to remove drug approval for the low blood pressure drug ProAmantine and its generics, which would result in a ProAmantine recall from the market.
